- Home
- Publications
- Publication Search
- Publication Details
Title
Exploring the role of oncolytic viruses in hepatobiliary cancers
Authors
Keywords
-
Journal
Immunotherapy
Volume -, Issue -, Pages -
Publisher
Future Medicine Ltd
Online
2018-06-14
DOI
10.2217/imt-2018-0048
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Neoadjuvant oncolytic virotherapy before surgery sensitizes triple-negative breast cancer to immune checkpoint therapy
- (2018) Marie-Claude Bourgeois-Daigneault et al. Science Translational Medicine
- Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2017) Jordi Bruix et al. LANCET
- Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial
- (2017) Anthony B El-Khoueiry et al. LANCET
- Enhancing the Oncolytic Activity of CD133-Targeted Measles Virus: Receptor Extension or Chimerism with Vesicular Stomatitis Virus Are Most Effective
- (2017) Dina Kleinlützum et al. Frontiers in Oncology
- Recombinant vaccinia virus GLV-1h68 is a promising oncolytic vector in the treatment of cholangiocarcinoma
- (2015) Amudhan Pugalenthi et al. CANCER GENE THERAPY
- Defining Effective Combinations of Immune Checkpoint Blockade and Oncolytic Virotherapy
- (2015) J. J. Rojas et al. CLINICAL CANCER RESEARCH
- Development of PROSTVAC immunotherapy in prostate cancer
- (2015) Parminder Singh et al. Future Oncology
- Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma
- (2015) Robert H.I. Andtbacka et al. JOURNAL OF CLINICAL ONCOLOGY
- Combination of the oral histone deacetylase inhibitor resminostat with oncolytic measles vaccine virus as a new option for epi-virotherapeutic treatment of hepatocellular carcinoma
- (2015) Benjamin Ruf et al. Molecular Therapy-Oncolytics
- Oncolytic Measles Virus Expressing the Sodium Iodide Symporter to Treat Drug-Resistant Ovarian Cancer
- (2014) E. Galanis et al. CANCER RESEARCH
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
- (2014) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Targeting gallbladder cancer: oncolytic virotherapy with myxoma virus is enhanced by rapamycin in vitro and further improved by hyaluronan in vivo
- (2014) Mingzhe Weng et al. Molecular Cancer
- Localized Oncolytic Virotherapy Overcomes Systemic Tumor Resistance to Immune Checkpoint Blockade Immunotherapy
- (2014) D. Zamarin et al. Science Translational Medicine
- Long-term remission of prostate cancer with extensive bone metastases upon immuno- and virotherapy: A case report
- (2014) VOLKER SCHIRRMACHER et al. Oncology Letters
- Treatment and Prognosis for Patients With Intrahepatic Cholangiocarcinoma
- (2014) Michael N. Mavros et al. JAMA Surgery
- Antiviral and Antitumor T-cell Immunity in Patients Treated with GM-CSF-Coding Oncolytic Adenovirus
- (2013) A. Kanerva et al. CLINICAL CANCER RESEARCH
- An armed oncolytic measles vaccine virus eliminates human hepatoma cells independently of apoptosis
- (2013) J Lampe et al. GENE THERAPY
- A Novel Armed Oncolytic Measles Vaccine Virus for the Treatment of Cholangiocarcinoma
- (2013) Sebastian Lange et al. HUMAN GENE THERAPY
- Systemically delivered measles virus-infected mesenchymal stem cells can evade host immunity to inhibit liver cancer growth
- (2013) Hooi-Tin Ong et al. JOURNAL OF HEPATOLOGY
- Antifibrotic Properties of Transarterial Oncolytic VSV Therapy for Hepatocellular Carcinoma in Rats With Thioacetamide-Induced Liver Fibrosis
- (2013) Jennifer Altomonte et al. MOLECULAR THERAPY
- Randomized dose-finding clinical trial of oncolytic immunotherapeutic vaccinia JX-594 in liver cancer
- (2013) Jeong Heo et al. NATURE MEDICINE
- Surgical Approach for Long-term Survival of Patients With Intrahepatic Cholangiocarcinoma
- (2012) Dario Ribero ARCHIVES OF SURGERY
- A randomized controlled trial of radiofrequency ablation and surgical resection in the treatment of small hepatocellular carcinoma
- (2012) Kai Feng et al. JOURNAL OF HEPATOLOGY
- Oncolytic virotherapy
- (2012) Stephen J Russell et al. NATURE BIOTECHNOLOGY
- Medium-Sized (3.1–5.0 cm) Hepatocellular Carcinoma: Transarterial Chemoembolization Plus Radiofrequency Ablation Versus Radiofrequency Ablation Alone
- (2011) Jin Hyoung Kim et al. ANNALS OF SURGICAL ONCOLOGY
- Early-Stage Gallbladder Cancer in the Surveillance, Epidemiology, and End Results Database
- (2011) Stephanie R. Downing ARCHIVES OF SURGERY
- Characterization of herpes simplex virus 1 strains as platforms for the development of oncolytic viruses against liver cancer
- (2011) Rafaela Argnani et al. LIVER INTERNATIONAL
- Recurrent Hepatocellular Carcinoma Treated with Sequential Transcatheter Arterial Chemoembolization and RF Ablation versus RF Ablation Alone: A Prospective Randomized Trial
- (2011) Zhen-Wei Peng et al. RADIOLOGY
- Systematic review on the surgical treatment for T1 gallbladder cancer
- (2011) Seung Eun Lee WORLD JOURNAL OF GASTROENTEROLOGY
- Surgical Resection of High-Risk Hepatocellular Carcinoma: Patient Selection, Preoperative Considerations, and Operative Technique
- (2010) Mark J. Truty et al. ANNALS OF SURGICAL ONCOLOGY
- A phase I clinical trial of thymidine kinase-based gene therapy in advanced hepatocellular carcinoma
- (2010) B Sangro et al. CANCER GENE THERAPY
- Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer
- (2010) Juan Valle et al. NEW ENGLAND JOURNAL OF MEDICINE
- Combination effect of oncolytic adenovirus therapy and herpes simplex virus thymidine kinase/ganciclovir in hepatic carcinoma animal models
- (2009) Fei-qun Zheng et al. ACTA PHARMACOLOGICA SINICA
- Transthyretin-driven oncolytic adenovirus suppresses tumor growth in orthotopic and ascites models of hepatocellular carcinoma
- (2009) Jeng-Long Hsieh et al. CANCER SCIENCE
- Oncolytic Gene Therapy Combined with Double Suicide Genes for Human Bile Duct Cancer in Nude Mouse Models
- (2009) Yoh Kojima et al. JOURNAL OF SURGICAL RESEARCH
- Newcastle disease virus represses the activation of human hepatic stellate cells and reverses the development of hepatic fibrosis in mice
- (2009) Ya-Lin Li et al. LIVER INTERNATIONAL
- Management and Extent of Resection for Intrahepatic Cholangiocarcinoma
- (2009) Darren R. Carpizo et al. Surgical Oncology Clinics of North America
- Impact of postoperative complications on long-term outcome of curative resection for hepatocellular carcinoma
- (2008) K. S. Chok et al. BRITISH JOURNAL OF SURGERY
- E1A, E1B double-restricted replicative adenovirus at low dose greatly augments tumor-specific suicide gene therapy for gallbladder cancer
- (2008) K Fukuda et al. CANCER GENE THERAPY
- Efficiency of adjuvant active specific immunization with Newcastle disease virus modified tumor cells in colorectal cancer patients following resection of liver metastases: results of a prospective randomized trial
- (2008) T. Schulze et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Synergistic antitumor effects of transarterial viroembolization for multifocal hepatocellular carcinoma in rats
- (2008) Jennifer Altomonte et al. HEPATOLOGY
- rVSV(MΔ51)-M3 Is an Effective and Safe Oncolytic Virus for Cancer Therapy
- (2008) Lan Wu et al. HUMAN GENE THERAPY
- Use of a targeted oncolytic poxvirus, JX-594, in patients with refractory primary or metastatic liver cancer: a phase I trial
- (2008) Byeong-Ho Park et al. LANCET ONCOLOGY
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
- Selectivein vitrocytotoxic effect of human cancer cells by Bluetongue virus-10
- (2007) Jun Hu et al. ACTA ONCOLOGICA
- Exponential Enhancement of Oncolytic Vesicular Stomatitis Virus Potency by Vector-mediated Suppression of Inflammatory Responses In Vivo
- (2007) Jennifer Altomonte et al. MOLECULAR THERAPY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search